Health care has had a tough year. Where we stand on our 5 stocks in the sector

[ad_1] There’s Eli Lilly (LLY), and then there’s everybody else. That’s a simple way to describe…

Here are the 8 trades and 3 price-target changes we made during a busy week

[ad_1] Our portfolio experienced a flurry of adjustments in a week dominated by Nvidia’s (NVDA) quarterly…

Jim Cramer talks about his ‘favorite stock,’ telling investors to buy some as we did last week

[ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at…

Here are the 5 price-target changes and 4 trades we made during this busy earnings week

[ad_1] In a jam-packed week of earnings, the Club executed multiple trades and elevated price targets…

These health-care companies see opportunity ahead from Alzheimer’s drug approval

[ad_1] As patients with Alzheimer’s disease seek out a newly approved treatment, they will need MRIs,…